Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Patient Factors Associated With Prescription of Antibiotics for Inappropriate Indication in Patients With AECOPD
NCT number | NCT03077152 |
Other study ID # | IGHCEAH |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2017 |
Est. completion date | September 1, 2018 |
Up to 90% of consulting Acute Exacerbation (AE) of COPD patients are prescribed an
antibiotic(1).
Rates of inappropriate antibiotic prescription percentage can be as high as 65%(2).
Excessive use of antibiotics is correlated with higher prevalence of antimicrobial
resistance(3). There are insufficient data regarding the overprescribing antibiotics in
AECOPD in our country.Therefore the investigators aimed to investigate the patients factors
that are associated with the prescription of antibiotic for inappropriate indication in
AECOPD.This is an observational cross sectional study.Population: AECOPD patients with
AB(antibiotic) prescription Exposure: Presence of patient factors, Comparison: Absence of
Patient factors, Outcome: Prescription of antibiotic for inappropriate indication.
Sampling:
Consecutive patients presenting to pharmacy between Monday and Friday. Date between January 1
2017 to January 1 30 2019. Primary Outcome:Prescription of antibiotic for inappropriate
indication according to Anthonisen criteria for AECOPD Anthonisen criteria:-Worsening of
dyspnea
- Increased sputum volume
- Increased sputum purulent 3/3 →Type 1 or severe AE 2/3 →Type 2 or moderate AE 1/3 →Type
3 or mild AE AB indicated/useful in Type 1 or severe AE, and Type 2 or moderate AE if
sputum is purulent The data will be obtained from the database.
Exposure:
Patient factors that lead to inappropriate antibiotic prescription (will be considered
together in analysis due to confounding) FEV1% Age Current smoker Comorbidities (Charlson
comorbidity index) having Frequent exacerbations (≥2 past year) Use of oral steroids
Polypharmacy Quality control:Detailed MOP will be developed, A manual for protocol will be
written and used to inform the pharmacist,Pharmacist will be trained; to speak to
participants in a neutral manner for written informed consent for the security ID(identity)
data of the patients,This study will not affect the time period of the participants to access
his/her drug. The pharmacy will use the questionnaire within the time period planned. A
checklist for exclusion criteria will be developed. A plan for missing data will be
developed.
Null hypothesis:
Patient factors are not associated with the prescription of antibiotics for inappropriate
indications in patients with AECOPD
Alternative hypothesis:
Patient factors are associated with the prescription of antibiotics for inappropriate
indications in patients with AECOPD Analysis The data will be analysed using SPSS version
22.0 The investigators will compare exposure variables between inappropriate and appropriate
prescription groups Continuous variables - t test or Mann Whitney Binary- chi square test The
investigators will use logistic regression to measure the associations between patient
factors and the outcome of prescription of antibiotics for inappropriate indication Sample
size and power Sample size to estimate CI of 15% around 25 to 50% prevalence of inappropriate
prescription with p=0.05 and Power 80% Expected proportion0,25 128 0,50 171 Sample size and
power For logistic regression - estimate 30% prevalence (n=143), or about 42 events . The
investigators also need 5-10 events for each variable in the model, so this provides
sufficient power for 4 to 8 factors.
Limitations This study will just determine an association not causality
The investigators won't be able to determine if the participant is truthful to the pharmacist
The history of participants will be assessed from hospitals e-database - potential for
missing data.
The Anthonisen criteria for identifying inappropriate AB for AECOPD are still debatable The
investigators can not modify many of the patient factors, but may be able to identify
patients at higher risk of inappropriate antibiotics Ethics The project will be submitted to
the ethical committee of Dr. Suat Seren Chest Disease Hospital Oral and written informed
consent will be obtained from all subjects The study will be conducted in accordance with
"Good Clinical Practice Guideline" Relevance This study will be the first one to evaluate an
association between patient factors and prescription of antibiotic for inappropriate
indication in an outpatient clinic of patients with AECOPD in Turkey.
Subsequent studies should evaluate physician factors prescription of antibiotic for
inappropriate indication.
Status | Completed |
Enrollment | 138 |
Est. completion date | September 1, 2018 |
Est. primary completion date | September 1, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Patients diagnosed with COPD according to GOLD criteria - Patients whom are prescripted an antibiotic for AECOPD in a chest diseases outpatient clinic - Prescriptions should be written by pulmonologists Exclusion Criteria: - COPD patients using Long term oxygen treatment (LTOT) at home - COPD patients using Bilevel Positive airway pressure (BPAP) for type 2 respiratory failure - COPD patients whom have snother need for AB use (bronchiectasis Pneumonia etc.) - COPD patients with Positive sputum culture past 4 weeks - COPD patients whom have Hospitalisation for COPD past 4 weeks |
Country | Name | City | State |
---|---|---|---|
Turkey | Dr. Suat Seren Chest Diseases and Surgery Education and Training Hospital | Izmir |
Lead Sponsor | Collaborator |
---|---|
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital |
Turkey,
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987 Feb;106(2):196-204. — View Citation
Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE; European Antimicrobial Resistance Surveillance System. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002 Mar;8(3):278-82. — View Citation
Llor C, Bjerrum L, Munck A, Hansen MP, Córdoba GC, Strandberg EL, Ovhed I, Radzeviciene R, Cots JM, Reutskiy A, Caballero L. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice. Ther Adv Respir Dis. 2013 Jun;7(3):131-7. doi: 10.1177/1753465812472387. Epub 2013 Jan 16. — View Citation
Tobia CC, Aspinall SL, Good CB, Fine MJ, Hanlon JT. Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clin Ther. 2008 Jun;30(6):1135-44. doi: 10.1016/j.clinthera.2008.06.009. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants who has a prescription of antibiotic for inappropriate indication for AECOPD according to Anthonisen criteria | Prescription of antibiotic is indicated in type 1 or severe exacerbation (3/3 Antjonisen critaria) or type 2 or moderate exacerbation if one of the symptoms are purulens of sputum.In mild exacerbation (1/3 criteria) it is not indicated. | 3 months | |
Secondary | Patient factors that may lead to prescribe inappropriate antibiotic prescription | Probable Patient factors that lead to inappropriate antibiotic prescription are FEV1%, Age, being a current smoker, carlson comorbidity index, being a frequent exacerbator, use of oral steroids and polifarmacy (will be considered together in analysis due to confounding) | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|